Company intelligence / Profile preview

Foldax

Salt Lake City, Utah, United Statesfoldax.com ↗

Ownership: Private
Development stage: Phase 1

Overview

Foldax has developed the world’s first synthetic polymer aortic and mitral heart valves using its proprietary LifePolymer™ material. The TRIA™ valves are designed to address durability and thrombogenicity issues of current tissue or mechanical valves. First-in-human use was successfully completed under an FDA Early Feasibility Study for the aortic position. Animal studies show no thrombosis or calcification on leaflet surfaces. The company aims to provide long-lasting, non-thrombogenic valves that do not require lifelong anticoagulation therapy.

Therapeutic areas: Cardiovascular
Modalities: DevicePolymer-based deviceBiologic
Industry: Implantable Medical Devices

Drug pipeline

3 assets

TRIA aortic valve

Phase 1

Indications: Aortic valve disease

2 more assets in the full pipeline.

Request access →

Partnerships

CaltechCSIRO (Commonwealth Scientific and Industrial Research Organisation)

Beyond the preview

Go deeper on Foldax.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Foldax.

Explore the full profile